Supernus Pharmaceuticals, Inc. (SUPN) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:

Not Rated

No Current Ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Hisham Hassan Hisham Hassan 12/26/2013 3 months $7.87 $8.64 +9.78% 9 Ended
InvestorsXpress InvestorsXpress 12/24/2013 1 day $7.40 $7.95 +7.43% 7 Ended
inBestment inBestment 08/20/2013 3 months $6.73 $7.12 +5.79% 5 Ended
tambor tambor 04/06/2013 3 months $5.45 $6.64 +21.83% 21 Ended
heathersandy heathersandy 03/20/2013 1 Year $5.51 $9.74 +76.77% 76 Ended
Comments: will be getting a good revenue stream from now on
cynthia m cynthia m 03/18/2013 1 Year $5.06 $9.90 +95.65% 95 Ended
Comments: 1 year outlook: $14
Chemistfrog Chemistfrog 01/01/2013 3 months $7.17 $5.62 -21.62% -21 Ended
Comments: Oversold due to terrible offering but has 2 approved epilepsy drugs. Rest of pipeline looks strong.
JOKER66 JOKER66 11/30/2012 1 day $9.83 $8.02 -18.41% 18 Ended

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.